Neuroprotection Bundles Comatose Survivors for in Cardiac Arrest Trial
Launched by XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · May 27, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The LAPTOPS trial is studying a new approach to care for adults who have survived a cardiac arrest, which is when the heart stops beating. Researchers want to see if a specific set of treatments, called a neuroprotection bundle, can help improve recovery compared to standard care. This bundle focuses on managing important health factors like body temperature, oxygen levels, and blood pressure to protect the brain after a patient has regained circulation.
To participate in this trial, individuals must be between 18 and 80 years old and have had a cardiac arrest where they were successfully resuscitated without needing CPR for more than 20 minutes. They also need to be unconscious after regaining circulation. Family members will need to provide consent for participation. If eligible, participants can expect close monitoring and specific treatments aimed at improving their chances of recovery. It’s important to note that this trial is not yet recruiting participants, but it aims to gather valuable information to enhance care for future patients who experience cardiac arrest.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years and \< 80 years
- • Patients of in-hospital or out-of-hospital cardiac arrest who have returned -spontaneous circulation (ROSC) after cardiopulmonary resuscitation and do not require CPR for more than 20 minutes;
- • Patients who are unconscious after ROSC, defined as FOUR motor response score \< 4 points or GSC ≤ 8 points;
- • Family members or legal representatives signed informed consent.
- Exclusion Criteria:
- • Unwitnessed cardiac arrest, estimated time from cardiac arrest to start of CPR \> 30 minutes;
- • Time from cardiac arrest to ROSC \> 60 minutes;
- • Patients who woke up immediately after ROSC by CPR;
- • End-stage diseases;
- • Cardiac arrest considered to be caused by neurological diseases;
- • The patient was in a vegetative state before cardiac arrest;
- • The interval from the onset of cardiac arrest to enrollment is \>72 hours .
About Xiangya Hospital Of Central South University
Xiangya Hospital of Central South University is a leading academic medical institution located in Changsha, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a key affiliate of Central South University, the hospital integrates clinical practice with medical education and research, fostering an environment that promotes the development of cutting-edge therapies and treatments. With a diverse array of specialized departments and a dedicated team of healthcare professionals, Xiangya Hospital actively participates in clinical trials aimed at enhancing medical knowledge and improving patient outcomes, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changsha, Hunan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported